Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe study details page for NCT03721679 appears unchanged between versions, with core content and structure the same and no additions or deletions detected.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check31 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0.SummaryDifference3%

- Check38 days agoChange DetectedThe page now shows Revision: v3.1.0 and no longer shows Revision: v3.0.2, indicating an update to the software version tag.SummaryDifference0.1%

- Check52 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has added significant information regarding various biochemical compounds and proteins, including specific antibodies and amino acids, while removing several terms related to immunological agents and location details.SummaryDifference4%

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.